Verve Therapeutics, Inc. (VERV) Social Stream
VERVE THERAPEUTICS INC (VERV) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering VERV.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-16 | 6 | $92 | $50 | $71.8 | $13.92 | 415.8% |
| 2022-01-12 | 6 | $92 | $50 | $74 | $13.92 | 431.61% |
| 2022-02-18 | 7 | $92 | $42 | $69.428 | $13.92 | 398.76% |
| 2022-03-15 | 7 | $92 | $34 | $64.285 | $13.92 | 361.82% |
| 2022-05-11 | 7 | $86 | $34 | $59.666 | $13.92 | 328.64% |
| 2022-05-17 | 8 | $84 | $34 | $55.333 | $13.92 | 297.51% |
| 2022-06-17 | 8 | $84 | $34 | $54.285 | $13.92 | 289.98% |
| 2022-08-09 | 7 | $75 | $34 | $50.666 | $13.92 | 263.98% |
| 2022-08-10 | 7 | $75 | $32 | $50.333 | $13.92 | 261.59% |
| 2022-11-07 | 7 | $75 | $36 | $54.333 | $13.92 | 290.32% |
| 2022-12-05 | 7 | $75 | $35 | $50.5 | $13.92 | 262.79% |
| 2022-12-15 | 8 | $75 | $13 | $45.142 | $13.92 | 224.3% |
| 2023-03-03 | 9 | $75 | $13 | $42.875 | $13.92 | 208.01% |
| 2023-04-20 | 9 | $75 | $13 | $42.444 | $13.92 | 204.91% |
| 2023-05-15 | 10 | $75 | $13 | $42.444 | $13.92 | 204.91% |
| 2023-05-16 | 10 | $75 | $13 | $42.111 | $13.92 | 202.52% |
| 2023-06-16 | 10 | $75 | $13 | $42.333 | $13.92 | 204.12% |
| 2023-08-11 | 10 | $75 | $13 | $39.875 | $13.92 | 186.46% |
| 2023-08-15 | 11 | $75 | $13 | $41.333 | $13.92 | 196.93% |
| 2023-11-07 | 11 | $75 | $13 | $42.8 | $13.92 | 207.47% |
| 2023-11-13 | 11 | $75 | $22 | $47.5 | $13.92 | 241.24% |
The Trend in the Analyst Price Target
VERV's average price target has moved down $30.5 over the prior 28 months.
Over the past 41 weeks, VERV's average upside potential has been 163.51%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-03 | 9 | 75 | 13 | 42.875 | 19.47 | 120.21% |
| 2023-06-16 | 10 | 75 | 13 | 42.333 | 19.90 | 112.73% |
| 2023-08-10 | 9 | 75 | 13 | 39.875 | 18.00 | 121.53% |
| 2023-11-07 | 11 | 75 | 13 | 42.800 | 18.70 | 128.88% |
| 2023-11-13 | 11 | 75 | 22 | 47.500 | 9.29 | 411.3% |
VERV Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.82 | 7 | 1 | 2 | 1 | 1 | 11 |
The Trend in the Broker Recommendations
VERV's average broker recommendation rating worsened by 0.02 over the prior 26 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for VERV as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, VERVE THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 2683.83% of them.
- VERVE THERAPEUTICS INC's variance in analysts' estimates is lower than -2530.45% of all US stocks.
- In the context of Pharmaceutical Products stocks, VERVE THERAPEUTICS INC's average analyst price target is higher than 2056.89% of them.
- VERVE THERAPEUTICS INC's number of analysts covering the stock is higher than 1671.07% of stocks in the mid market cap category.
Stocks similar to VERVE THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ATAI, VIR, and AMRX.
View All Top Stocks by Price Target
Is VERV a Buy, Hold or Sell? See the POWR Ratings now!